Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
COVID-19 encompasses a broad spectrum of clinical conditions caused by SARS-CoV-2 infection. More severe cases experience acute respiratory and/or multiorgan failure. KL-6 is a glycoprotein expressed mainly from type II alveolar cells with pro-fibrotic properties. Serum KL-6 concentrations have been...
Main Authors: | Vito D’Agnano, Filippo Scialò, Francesco Perna, Lidia Atripaldi, Stefano Sanduzzi, Valentino Allocca, Maria Vitale, Lucio Pastore, Andrea Bianco, Fabio Perrotta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/8/1141 |
Similar Items
-
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
by: Noha Hosni Ibrahim, et al.
Published: (2023-11-01) -
Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
by: Myeong Geun Choi, et al.
Published: (2022-12-01) -
Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
by: Jie He, et al.
Published: (2022-11-01) -
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
by: Ivan Castellví, et al.
Published: (2022-08-01) -
Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis
by: Michal Matuszewski, et al.
Published: (2022-11-01)